Why Industry Giants Are Rewriting EPA Science
April 2026 | An Expert-Level Analysis | SustainabilityAwakening.com
The Core Revelation
The EPA just appointed a 36-member science board heavily featuring executives from ExxonMobil, Dow, and Chemours.
An Uneasy Alliance
While universities like Yale and Columbia are represented, powerful corporate voices now share the gavel.
The Conflict of Interest?
These newly appointed companies have direct financial stakes in the exact chemicals the EPA regulates.
The PFAS Problem
Critics highlight that these specific firms have histories of severe PFAS contamination and water lawsuits.
Fear of Industry Capture
Environmental experts warn this makeup risks sacrificing public health protections for corporate lobbying.
The Board's Defenders
Supporters argue these executives bring diverse, practical scientific credentials to theoretical policy.
A Historical Precedent
Mixed boards have existed before under strict disclosure rules, but the current balance is raising alarms.
The Immediate Target
Why now? This new advisory board is gearing up to shape a sweeping wave of upcoming deregulatory efforts.
Shifting the System
This reflects a massive shift in U.S. ecological economics toward industry-led environmental management.
The Future of Oversight
As the line between regulator and regulated blurs, the foundational safety of our air and water is at stake.